Wits RHI
Research team
Infectious morbidity among children HIV-exposed uninfected in South Africa
Infectious morbidity among children HIV-exposed uninfected in South Africa
Consultation report – gonococcal immunoassays and standards for vaccine development
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
News in Research
New research shows first population-level evidence globally that a national…
Professor Sinead Delany-Moretlwe presented findings from the HPTN 084 open-label…
In a recent Health-e News feature, Wits RHI’s Director of…
Footer
Established in 1994, Wits RHI is part of the Faculty of Health Sciences and the leading research institute of the University of the Witwatersrand.